Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Study-group on Palliative ERCP And RFA-ablation in Metastatic and Inoperable Pancreatic Tumors [NA]
Clinical trial investigating palliative endoscopic retrograde cholangiopancreatography (ERCP) with radiofrequency ablation (RFA) for metasta…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples [Phase 2]
This Phase 2 clinical trial is evaluating PurIST classification-guided adaptive neoadjuvant chemotherapy for pancreatic cancer using RNA exp…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
The MOMENTUM study is evaluating radiation therapy using an MR-Linac across multiple cancer types and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Evaluating Health Literacy, Expectations and Regrets in Patients Undergoing Major Abdominal Surgery for Malignant Disease
This clinical trial evaluates health literacy, expectations, and regrets in patients undergoing major abdominal surgery for malignant diseas…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: TR-002 for the Treatment of Advanced, Unresectable or Metastatic Solid Tumors and Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma [Phase 1]
A Phase 1 clinical trial evaluating TR-002 for advanced unresectable or metastatic solid tumors and unresectable or metastatic pancreatic ad…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
This clinical trial update outlines a study evaluating gastrointestinal cancer biomarkers in tissue and biological fluids from colorectal ca…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: FAZA PET/MRI Pancreas [NA]
A FAZA PET/MRI imaging study for pancreatic cancer that is unresectable or locally advanced is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: ctDNA Assay in Patients With Resectable Pancreatic Cancer
This clinical trial update describes an ongoing study evaluating a circulating tumor DNA (ctDNA) assay in patients with resectable pancreati…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
This update covers the INSPPIRE 2 study, a pediatric biospecimen collection effort to identify gene mutations associated with high-risk panc…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast
Expanded access (compassionate use) for the DNG64-CAR-V cell therapy in patients with advanced pancreatic cancer, various sarcoma subtypes, …
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases
A planned clinical trial uses endoscopic ultrasound-guided circulating tumor cells combined with multi-omics to predict recurrence and metas…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer [Phase 3]
Phase III study evaluating Ivonescimab plus chemotherapy with or without AK117 in metastatic pancreatic cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer [Phase 2]
A Phase 2 clinical trial is evaluating tumor-infiltrating lymphocyte immunotherapy for multiple metastatic cancers and is currently recruiti…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Efficacy of Tunlametinib in Combination With Anti-EGFR Monoclonal Antibody in Patients With RAS-Mutated Advanced Gastrointestinal Malignancies [Phase 2]
A Phase 2 clinical trial update evaluating tunlametinib in combination with an anti-EGFR monoclonal antibody for RAS-mutated advanced colore…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial evaluating AK130 in combination with AK112 for advanced pancreatic cancer is currently in the recruitment phase.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: IDOV-Immune for Advanced Solid Tumors [Phase 1]
This report summarizes a Phase 1 trial of IDOV-Immune from ViroMissile, Inc. for advanced solid tumors, which is currently recruiting across…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC) [Phase 1, Phase 2]
Phase I/II trial of nab-paclitaxel plus gemcitabine with proton therapy for locally advanced pancreatic cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
This entry notes a Johns Hopkins University-sponsored study evaluating diagnostic strategies, risk assessment, and progression of pancreatic…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation for Patients With Resectable Pancreatic Cancer [Phase 3]
A Phase 3 trial update for Tele-PancFit, a multi-site video-based prehabilitation program aimed at improving strength before pancreatic canc…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial evaluating hV01, a recombinant human IL-21-expressing oncolytic vaccinia virus, for advanced pancreatic cancer is c…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury [Phase 2]
Phase 2 clinical trial evaluating the PET imaging probe [68Ga]CBP8 for detecting radiation-induced tissue injury in patients with lung and p…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: AI-Powered Precision Decision-Making for Pancreatic Diseases
An ongoing clinical trial evaluating AI-powered precision decision-making for pancreatic diseases. Recruitment is currently in progress.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer [NA]
A clinical trial at Ohio State University is evaluating DCE-MRI guided neoadjuvant chemotherapy for borderline-resectable pancreatic cancer …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer [Phase 3]
A Phase 3 trial is planned to compare surufatinib plus gemcitabine and nab-paclitaxel against gemcitabine and nab-paclitaxel as neoadjuvant …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer [Phase 1, Phase 2]
This document provides an update on a Phase 1/2 clinical trial evaluating EDV Nanocell Therapy in combination with gemcitabine and nab-pacli…